comparison of glp-1 agonists Treatment with Receptor Comparison of short-acting versus long-acting
Description
Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism
Liraglutide attenuates diabetic cardiomyopathy via the ILK/PI3K/AKT/PTEN signaling pathway in rats with streptozotocin-induced type 2 diabetes mellitus
Not as powerful as tirzepatide or retatrutide in head-to-head data
Blood 125 , 284295 (2015)
Emmerich SD et al
